Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TISSUE DIAGNOSTICS INSTRUMENT INDUSTRY
2.1 Summary about Tissue Diagnostics Instrument Industry
2.2 Tissue Diagnostics Instrument Market Trends
2.2.1 Tissue Diagnostics Instrument Production & Consumption Trends
2.2.2 Tissue Diagnostics Instrument Demand Structure Trends
2.3 Tissue Diagnostics Instrument Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Slide-staining Systems
4.2.2 Scanners
4.2.3 Tissue-processing Systems
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast cancer
4.3.2 Gastric cancer
4.3.3 Lymphoma
4.3.4 Prostate cancer
4.3.5 Non-small cell lung cancer
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Slide-staining Systems
5.2.2 Scanners
5.2.3 Tissue-processing Systems
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast cancer
5.3.2 Gastric cancer
5.3.3 Lymphoma
5.3.4 Prostate cancer
5.3.5 Non-small cell lung cancer
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Slide-staining Systems
6.2.2 Scanners
6.2.3 Tissue-processing Systems
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast cancer
6.3.2 Gastric cancer
6.3.3 Lymphoma
6.3.4 Prostate cancer
6.3.5 Non-small cell lung cancer
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Slide-staining Systems
7.2.2 Scanners
7.2.3 Tissue-processing Systems
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast cancer
7.3.2 Gastric cancer
7.3.3 Lymphoma
7.3.4 Prostate cancer
7.3.5 Non-small cell lung cancer
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Slide-staining Systems
8.2.2 Scanners
8.2.3 Tissue-processing Systems
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast cancer
8.3.2 Gastric cancer
8.3.3 Lymphoma
8.3.4 Prostate cancer
8.3.5 Non-small cell lung cancer
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Slide-staining Systems
9.2.2 Scanners
9.2.3 Tissue-processing Systems
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast cancer
9.3.2 Gastric cancer
9.3.3 Lymphoma
9.3.4 Prostate cancer
9.3.5 Non-small cell lung cancer
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche (Switzerland)
10.1.2 Danaher (US)
10.1.3 Thermo Fisher Scientific (US)
10.1.4 Abbott (US)
10.1.5 Agilent Technologies (US)
10.1.6 Merck (Germany)
10.1.7 Sakura Finetek Japan (Japan)
10.1.8 Abcam (UK)
10.1.9 BD (US)
10.1.10 QIAGEN (Netherlands)
10.1.11 Sienna Cancer Diagnostics (Australia)
10.1.12 Royal Philips (Netherlands)
10.1.13 A. Menarini Diagnostics (Italy)
10.1.14 Cell Signaling Technology (US)
10.1.15 Enzo Life Sciences (US)
10.1.16 Master Diagnóstica (Spain)
10.1.17 TissueGnostics (Austria)
10.1.18 Bio SB (US)
10.1.19 MedImmune (US)
10.1.20 Cernostics (US)
10.2 Tissue Diagnostics Instrument Sales Date of Major Players (2017-2020e)
10.2.1 Roche (Switzerland)
10.2.2 Danaher (US)
10.2.3 Thermo Fisher Scientific (US)
10.2.4 Abbott (US)
10.2.5 Agilent Technologies (US)
10.2.6 Merck (Germany)
10.2.7 Sakura Finetek Japan (Japan)
10.2.8 Abcam (UK)
10.2.9 BD (US)
10.2.10 QIAGEN (Netherlands)
10.2.11 Sienna Cancer Diagnostics (Australia)
10.2.12 Royal Philips (Netherlands)
10.2.13 A. Menarini Diagnostics (Italy)
10.2.14 Cell Signaling Technology (US)
10.2.15 Enzo Life Sciences (US)
10.2.16 Master Diagnóstica (Spain)
10.2.17 TissueGnostics (Austria)
10.2.18 Bio SB (US)
10.2.19 MedImmune (US)
10.2.20 Cernostics (US)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Tissue Diagnostics Instrument Product Type Overview
2.Table Tissue Diagnostics Instrument Product Type Market Share List
3.Table Tissue Diagnostics Instrument Product Type of Major Players
4.Table Brief Introduction of Roche (Switzerland)
5.Table Brief Introduction of Danaher (US)
6.Table Brief Introduction of Thermo Fisher Scientific (US)
7.Table Brief Introduction of Abbott (US)
8.Table Brief Introduction of Agilent Technologies (US)
9.Table Brief Introduction of Merck (Germany)
10.Table Brief Introduction of Sakura Finetek Japan (Japan)
11.Table Brief Introduction of Abcam (UK)
12.Table Brief Introduction of BD (US)
13.Table Brief Introduction of QIAGEN (Netherlands)
14.Table Brief Introduction of Sienna Cancer Diagnostics (Australia)
15.Table Brief Introduction of Royal Philips (Netherlands)
16.Table Brief Introduction of A. Menarini Diagnostics (Italy)
17.Table Brief Introduction of Cell Signaling Technology (US)
18.Table Brief Introduction of Enzo Life Sciences (US)
19.Table Brief Introduction of Master Diagnóstica (Spain)
20.Table Brief Introduction of TissueGnostics (Austria)
21.Table Brief Introduction of Bio SB (US)
22.Table Brief Introduction of MedImmune (US)
23.Table Brief Introduction of Cernostics (US)
24.Table Products & Services of Roche (Switzerland)
25.Table Products & Services of Danaher (US)
26.Table Products & Services of Thermo Fisher Scientific (US)
27.Table Products & Services of Abbott (US)
28.Table Products & Services of Agilent Technologies (US)
29.Table Products & Services of Merck (Germany)
30.Table Products & Services of Sakura Finetek Japan (Japan)
31.Table Products & Services of Abcam (UK)
32.Table Products & Services of BD (US)
33.Table Products & Services of QIAGEN (Netherlands)
34.Table Products & Services of Sienna Cancer Diagnostics (Australia)
35.Table Products & Services of Royal Philips (Netherlands)
36.Table Products & Services of A. Menarini Diagnostics (Italy)
37.Table Products & Services of Cell Signaling Technology (US)
38.Table Products & Services of Enzo Life Sciences (US)
39.Table Products & Services of Master Diagnóstica (Spain)
40.Table Products & Services of TissueGnostics (Austria)
41.Table Products & Services of Bio SB (US)
42.Table Products & Services of MedImmune (US)
43.Table Products & Services of Cernostics (US)
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) Share by Demand 2021f-2026f